Pharma sales to grow beyond $1 trillion

New findings forecast global pharma sales to grow past 2014’s $1 trillion to $1.3 trillion by 2018

The Intellectual Property and Science business of Thomson Reuters, a provider of intelligent information for businesses and professionals announced the release of the 2015 CMR Pharmaceutical R&D Factbook.

Despite concerns around declines in research and development, the analysis identifies a surge in global sales with 2014’s $1 trillion milestone and forecasts sales to reach $1.3 trillion by 2018.

It also reveals a positive shift in new molecular entities (NMEs) with 46 launches in 2014; the highest in over a decade.

The study underscores a promising industry outlook with increases in sales and NME launches and with shifting trends in R&D pipeline volume and therapeutic areas as evidenced by these other key findings:

·         Diversification increases NME launches

·         Anti-cancer dominates

·         Increase in failing fast and cheaply

Basil Moftah, president, Thomson Reuters IP & Science, said: “This is an extraordinary year for pharma.

“Not only do  the critical insights provided by the Factbook challenge negative perceptions, but it demonstrates this industry’s continued commitment to creating and  employing  innovative solutions to tackle its largest hurdles.”

Learn more about the CMR Factbook.